Carregant...
Megestrol acetate for cachexia–anorexia syndrome. A systematic review
In 1993, megestrol acetate (MA) was approved by the US Food and Drug Administration for the treatment of anorexia, cachexia, or unexplained weight loss in patients with acquired immunodeficiency syndrome. The mechanism by which MA increases appetite is unknown, and its effectiveness for anorexia and...
Guardat en:
| Publicat a: | J Cachexia Sarcopenia Muscle |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley and Sons Inc.
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5989756/ https://ncbi.nlm.nih.gov/pubmed/29542279 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jcsm.12292 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|